This trial is testing an anti-obesity medication to see how well it works in helping people lose weight and keep it off. The results could help lead to new medications for obesity.
1 Primary · 1 Secondary · Reporting Duration: Change between baseline and month four of treatment.
Active Control
Non-Treatment Group
100 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention Group · Has Placebo Group · Phase 3
Age 18 - 75 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:California | 38.5% |
Georgia | 7.7% |
Ohio | 7.7% |
Other | 46.2% |
18 - 65 | 100.0% |
Loma Linda University Health | 100.0% |
Met criteria | 41.7% |
Did not meet criteria | 58.3% |
0 | 66.7% |
1 | 16.7% |
3+ | 16.7% |
Phone Call | 100.0% |